T1	Participants 82 126	treated with anthracycline-based chemotherap
T2	Participants 303 339	patients treated with anthracyclines
T3	Participants 434 473	42 patients treated with anthracyclines
T4	Participants 620 848	21 men and 21 women with a mean age of 55 ± 17 years, who presented a median of 84 months after chemotherapy with a cumulative anthracycline exposure of 282 ± 65 mg/m(2) and a mean left ventricular ejection fraction of 52 ± 12%.
